Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound-Reference-Cited by-同舟云学术

Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound

Published:2010-01 Issue:2 Volume:138 Page:157-165
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Nakayama Takashi,Komiyama Nobuyuki,Yokoyama Masaki,Namikawa Susumu,Kuroda Nakabumi,Kobayashi Yoshio,Komuro Issei

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Diabetes and cardiovascular disease. The Framingham study;Kannel;JAMA,1979

2. Myocardial infarction in patients with diabetes mellitus;Malmberg;Eur Heart J,1988

3. Outcome of unstable angina in patients with diabetes mellitus;Fava;Diabet Med,1997

4. Demonstration of insulin resistance in coronary artery disease documented with angiography;Shinozaki;Diabetes Care,1996

5. Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study;Takagi;J Am Coll Cardiol,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between bifurcation angle of the left main coronary artery and severity of stenosis of the proximal left anterior descending artery;Cardiovascular Journal of Africa;2023-06-30

2. Effect of pioglitazone, as antidiabetic agent, on atheroma regression in type 2 diabetic patients: a systematic review and meta-analysis;Beni-Suef University Journal of Basic and Applied Sciences;2021-02-03

3. Targeting smooth muscle cell phenotypic switching in vascular disease;JVS: Vascular Science;2021

4. Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes;Atherosclerosis;2020-05

5. Diabetic Vascular Damage: Review of Pathogenesis and Possible Evaluation Technologies;IEEE Access;2019